Updated Risk Assessment of Cannabidiol in Foods Based on Benchmark Dose–Response Modeling
Molecules · 2024
DOI: 10.3390/molecules29194733 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2024. Verfasst von Eva Wisotzki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Study of Toxicology and Environmental Protection, Rudolf-Boehm-Institut für Pharmakologie und Toxikologie, Universität Leipzig, Härtelst…. Hauptthemen laut MEDLINE: Cannabidiol. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cannabidiol (CBD), a non-psychotropic main component of the Cannabis plant, has been approved as a drug in the European Union (EU) under the name “Epidyolex”. However, its approval process as a food ingredient under the Novel Food Regulation was paused by the European Food Safety Authority (EFSA) due to a lack of safety data. Nevertheless, there is a growing, unregulated market in which CBD is advertised with various health claims and dosage instructions. Of particular concern is its toxic effect on the liver and possible reproductive toxicity in humans. Studies suitable for calculating the benchmark dose were identified from the available data. Animal studies yielded a benchmark dose lower confidence limit (BMDL) of 43 mg/kg bw/day, which translates into a safe human dose of approximately 15 mg/day. Only the Lowest-Observed-Adverse-Effect Level (LOAEL) of 4.3 mg/kg bw/day could be identified from the human data. This updated risk assessment confirmed a health-based guidance value (HBGV) of 10 mg/day based on human LOAEL. Despite the existing data gaps, preliminary regulation appears advisable because the current form of the gray CBD market is unacceptable from the standpoint of consumer safety and protection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postgraduate Study of Toxicology and Environmental Protection, Rudolf-Boehm-Institut für Pharmakologie und Toxikologie, Universität Leipzig, Härtelstrasse 16-18, 04107 Leipzig, Germany.
- Chemisches und Veterinäruntersuchungsamt (CVUA) Karlsruhe, Weissenburger Strasse 3, 76187 Karlsruhe, Germany.
ORCID-Profile: Heike Franke, Stephan G Walch, Dirk W Lachenmeier
Zitieren
APA
Wisotzki, E., Franke, H., Sproll, C., Walch, S. G., & Lachenmeier, D. W. (2024). Updated Risk Assessment of Cannabidiol in Foods Based on Benchmark Dose–Response Modeling. Molecules. https://doi.org/10.3390/molecules29194733
Vancouver
Wisotzki E, Franke H, Sproll C, Walch SG, Lachenmeier DW. Updated Risk Assessment of Cannabidiol in Foods Based on Benchmark Dose–Response Modeling. Molecules. 2024. doi:10.3390/molecules29194733
BibTeX
@article{Wisotzki2024,
author = {Wisotzki, Eva and Franke, Heike and Sproll, Constanze and Walch, Stephan G and Lachenmeier, Dirk W},
title = {Updated Risk Assessment of Cannabidiol in Foods Based on Benchmark Dose–Response Modeling},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29194733}
}
EUVIMED